Major trial tests new hope for deadly lung pressure disease
Disease control
Not yet recruiting
This Phase 3 study is testing whether the experimental drug IKT-001 can help adults with pulmonary arterial hypertension, a serious condition where blood pressure in the lungs is dangerously high. Researchers will measure if the drug reduces pressure in the lung's blood vessels a…
Phase: PHASE3 • Sponsor: Inhibikase Therapeutics • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC